Vincerx Pharma Inc
VINC
Market Cap$306.73K
Close$
$0.48
704.5% upside
Current Fair Value
704.5% upsideUndervalued by 704.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $306,729.00 |
|---|---|
| Enterprise Value | $-4,680,271.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-15.85 |
| Beta | 1.39 |
| Outstanding Shares | 11,649,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.12 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -3.56 |
| Enterprise Value to EBIT | 0.17 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Vincerx Pharma Inc
28 employeesVincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment ...